FDA Inspection 635534 — Kyle Patrick, DO

Kyle Patrick, DO — FEI 3007145092

The FDA completed an inspection of Kyle Patrick, DO on Dec 9, 2009 in Phoenix, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Phoenix, AZ (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance